Ventyx Biosciences Inc
Biotechnology
Healthcare
VTYX
70.67 M shares
NASDAQ US
traded
24 Mar 2025
listed
no
open
1.33
52 week high
5.28
high
1.37
52 week low
1.32
low
1.31
growth
-71.96 %
previous Close
1.32
P/E ratio
market cap
161 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-35.25 M
-10.33 %
eps
0.00 %
-11.11 %
eps surprise
3.85 %
net profit margin
-3524900000.00 %
0.00 %
operating incoming
-38.55 M
-7.95 %
net change in cash
20.84 M
120.64 %
cash on hand
61.77 M
50.92 %
cost of revenue
0.00 %
top top